Ok Lads the ball game has changed a little after this presentation. As an avid fan and researcher of the man a few things are evident.
1)The company is cashed up from a cohort of committed investors 2)Washer used the shell from ECQ to acquire Cynata - we knew this. 3) Washer mentions in conjunction with the warf they are listing the technology - the home of stem cells. 4) He talks valuation - sees a 5 fold change + over the next 12 months. 5) Talks of the opportunity to sell technology to majors - license Cymerus and in fact welcomes it.
This is a pivotal point for Cynata - Punters make no mistake the wheels have been greased for a dramatic rerating. In less than 9 months we will have a partner imo.
I was a seed investor in ISN @ 5c and have followed Washer very closely. He has great support and reputation as does Mike Thomas who I contact regularly. I think this is a very pivotal time in our investment in Cynata. From these levels there may be a lot of money to be made here indeed also on the options.
All the best into 2014 this should be good from here.
ECQ Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held